OTCA14 ”Robot-assisted surgery in thoracic and visceral indications”.” Final Assessment Now Available
We are pleased to announce publication of the collaborative assessment OTCA14 “Robot-assisted surgery for thoracic and visceral surgery”. This is the assessment of the relative effectiveness and safety of robot-assisted surgery for 13 different procedures within the thoracic and visceral surgery
OTCA18 Final Project Plan – Regional hyperthermia for high-risk soft tissue sarcoma treatment – now available
The Final OTCA18 Project Plan on 'Regional hyperthermia for high-risk soft tissue sarcoma treatment' is now available for access, together with comments from external experts, Haukeland Hospital, and manufacturers, and the relevant answers for each from the assessment team. Please access
REQueST® tool and its Vision paper are now available for Public Consultation
The Haute Autorité de Santé (HAS), National Institute for Health and Care Excellence (NICE) & the Croatian Institute for Public Health (HZJZ) are pleased to share the following WP5 strand B draft outputs for an 8 week public consultation: REQueST (Registry Evaluation
OTCA11 Final Assessment – Now Available
We are pleased to announce that the collaborative rapid assessment, OTCA11, on "Custom-made or customisable 3D printed implants and cutting guides versus non-3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery"
EUnetHTA 2019 Assembly & Forum Welcome Guide – Now Available
To accompany the upcoming EUnetHTA 2019 Assembly & Forum 0n 10-11th April in Amsterdam, a Welcome Guide has been developed to give participants and attendees a thorough overview of the event proceedings, practical information, and EUnetHTA's working activities. The guide is
Declaration of Interest and Confidentiality Undertaking (DOICU) – Documents Now Available
EUnetHTA has developed documentation to address Conflict of Interest (COI) concerns and assist in the decision-making process relating to the assessment of individuals potentially involved in EUnetHTA JA3 activities. The Procedure Guidance for handling Declaration of Interest and Confidentiality Undertaking
Open Call for Patient Input – Joint Assessment on a medicinal product for secondary progressive MS.
EUnetHTA recently started a new Joint Assessment on a medicinal product for secondary progressive MS. To find out about participation, please read more here. Input submissions will be received through till EOB, April 28th.
2019 EUnetHTA Forum Agenda – Now Available
The day's agenda is now available for the upcoming 2019 EUnetHTA Forum on 11th April at the West-Indisch Huis in central Amsterdam. We are looking forward to hosting a collaborative, informative session of talks that both outline progress made in European
EUnetHTA Magazine: Winter 2019
Assessment Publication: Jointly Produced HTA Report; Partner Profile: Austria; Impact: Austria; Partner Profile: UK; Innovation & HTA: Giovanni Tafuri; Prioritisation List: Topics & Joint Assessments; 2018: Year in Review Download your copy HERE.
PTJA04 Final Project Plan – Sotagliflozin for adult patients with Type 1 Diabetes Mellitus who have inadequate blood glucose control using insulin or insulin analogues
Please see the below Final Project Plan of the Fourth Pharma Joint Assessment on 'sotagliflozin for adult patients with Type 1 Diabetes Mellitus who have inadequate blood glucose control using insulin or insulin analogues.' Timelines will change slightly due to the